Identifying low-risk patients for bacterial meningitis in adult patients with acute meningitis

Yasuharu Tokuda1, Masahiro Koizumi, Gerald H Stein

  • 1Center for Clinical Epidemiology, St. Luke's Life Science Institute, Tokyo, Japan. tokuyasu@orange.ocn.ne.jp

Abstract

Insights

This study developed a sensitive clinical prediction model to differentiate bacterial meningitis (BM) from aseptic meningitis (AM). The model accurately identifies low-risk patients, potentially avoiding unnecessary antibiotic treatment for bacterial meningitis.

Area of Science:

  • Clinical prediction modeling
  • Infectious disease diagnostics
  • Neurology and critical care

Background:

  • Distinguishing between aseptic meningitis (AM) and bacterial meningitis (BM) is critical for appropriate patient management.
  • Bacterial meningitis requires prompt antibiotic treatment, while aseptic meningitis does not.
  • Accurate and sensitive diagnostic tools are needed to guide clinical decisions and prevent overtreatment.

Purpose of the Study:

  • To derive and validate a clinical prediction model with high sensitivity for differentiating AM from BM.
  • To develop a tool that can safely identify patients with a low risk of bacterial meningitis.

Main Methods:

  • A clinical prediction model was developed using recursive partitioning analysis on a derivation cohort from a rural hospital.
  • The model's performance was validated using a separate cohort from an urban hospital.
  • Key variables identified included Gram stain, CSF neutrophil percentage, CSF neutrophil count, and mental status change.

Main Results:

  • The derived model demonstrated high sensitivity in both derivation (99%) and validation (100%) cohorts.
  • In the derivation cohort, 99% of bacterial meningitis cases were correctly classified.
  • In the validation cohort, 100% of bacterial meningitis cases were correctly classified, with no BM patients in the low-risk group.

Conclusions:

  • A simple, sensitive clinical prediction model effectively differentiates bacterial meningitis from aseptic meningitis.
  • This model can safely identify low-risk patients who may not require antibiotic therapy.
  • The tool has potential utility in clinical settings to guide treatment decisions for meningitis.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...